Guggenheim Upgrades Salesforce (CRM) to Buy From Neutral
1 min read
The story
Guggenheim has lifted its rating on Salesforce (CRM) to Buy from Neutral, marking a meaningful shift from one of the more cautious voices on the name. The call lands with CRM reporting $41.5B in revenue — up 9.6% year-over-year — with a healthy 77.7% gross margin and a 18.0% net margin, suggesting the profitability story Salesforce has been building is gaining credibility with sell-side analysts.
The upgrade matters because Guggenheim tends to move gradually; flipping to Buy from Neutral is a signal that the firm sees a more compelling risk/reward at current levels, likely tied to margin expansion sustaining and the AI-driven product cycle (Agentforce) beginning to show up in bookings data. CRM's $7.80 diluted EPS gives the stock a tangible earnings anchor as the FY ending January 2026 approaches.
The setup is a classic single-upgrade story: it can act as a near-term sentiment catalyst, but the real test is whether subsequent prints confirm the thesis. Bears will note that 9.6% revenue growth, while solid, is not the hyper-growth pace that historically commanded CRM's premium multiple, and competition from Microsoft Dynamics and ServiceNow remains intense.
Watch for whether other mid-tier analysts follow Guggenheim's lead in the coming weeks — a cluster of upgrades would materially tighten the bull case. The FY2026 earnings print (expected late February/early March 2026) is the hard catalyst that will validate or undercut this call.
The case — both sides
CRM's net margin expansion to 18% — a structural shift Guggenheim is directly citing — combined with the Agentforce AI upsell cycle creates a credible path to multiple re-rating as the market reprices the name from growth-at-all-costs to durable-profit compounder.
At a premium SaaS multiple, 9.6% revenue growth leaves limited margin for error — if the FY2026 print or guidance disappoints on RPO or billings, the stock's valuation premium versus lower-growth peers like Oracle or SAP becomes hard to defend, and the upgrade quickly looks like a timing miss.
The house read
Leans bullWith Guggenheim moving to Buy and CRM's margins expanding, the question is whether the upgrade cycle broadens enough to sustain a re-rating, or whether modest revenue growth and a premium multiple cap further upside.
Wrong ifRevenue growth at 9.6% YoY is decelerating relative to CRM's historical pace; if the FY2026 print shows further deceleration or weak RPO/billings growth, the upgrade thesis collapses quickly and the multiple contracts. A broader risk-off move in high-multiple SaaS also kills this trade independent of fundamentals.
Published read · research, not advice